Inserm Unit 1124, “Toxicology, Pharmacology and Cellular Signaling” (Paris Descartes University/Inserm)
+ 33 (0) 1 42 86 20 75
In December 2015, France will host the 21st Session of the Conference of the Parties to the United Nations Framework Convention on Climate Change (COP21). This international conference highlights the willingness of the 200 participating governments to limit climate disruption and its consequences for the Earth’s natural system.
To ensure its success, numerous activities are being arranged prior to COP21. From 7 to 11 July, UNESCO is organising a scientific conference entitled “Our Common Future Under Climate Change.” The aim is to assess the risks from climate change from a scientific point of view, and to propose actions for reducing carbon emissions.
In this context, Inserm is committed to highlighting the crucial role that health and those working in the health sector can play in the coming months and years to make climate-related issues a central concern for our societies. Indeed, we often forget that if global warming is affecting the planet’s ecosystem, the fauna and flora, we are also in the front line of its effects. Conversely, we can also have an influence on climate. For example, by changing our diet to one based on vegetables and less meat, it would be possible to reduce greenhouse gas emissions by 40%.
This meeting, “Current and Future Research trends on Climate Change and Health,” will be held in Paris:
Monday 6 July 2015, 2:00–6:00 pm in the auditorium at Paris Biopark, 11 rue Watt, Paris 13th Arrondissement.
In the company of:
Yves Lévy – Chairman and CEO of Inserm, and President of Aviesan
Robert Barouki – Director of Inserm Unit 1124 (Inserm/Paris Descartes University)
And many researchers from Inserm, who will be coming to share the results of their work on the effects of climate change on health.
For more information: the conference program
 Green, R, Milner, J, Dangour, AD et al. The potential to reduce greenhouse gas emissions in the UK through healthy and realistic dietary change. Clim Change. 2015; 129: 253–265
Knowledge of the genetic component of Alzheimer's disease continues to deepen. The aim is not to predict the disease but reveal its pathophysiological mechanisms in order to develop new drugs. At Lille’s Institut Pasteur, an Inserm team led by Jean Charles Lambert ...
A trial sponsored by AP-HP and conducted by teams of Beaujon Hospital, AP-HP, Inserm and Université Paris Diderot was set up to establish an indicator that reflects the severity of liver disease in patients with cirrhosis. Coordinated by Professor Pierre-Emmanuel Rautou and ...
Health can help saving negotiation on climate change
Antoine Flahaultemail, Stefanie Schütte, Jean-François Guégan, Mathilde Pascal, Robert Barouki on behalf of 14 signatories The Lancet, 13 june 2015